A common physical basis for the gastric mucosal barrier and the action of sucralfate
- PMID: 1882905
- DOI: 10.1016/0002-9343(91)90450-c
A common physical basis for the gastric mucosal barrier and the action of sucralfate
Abstract
A novel explanation for the action of sucralfate in gastric ulcers has been proposed based on a new theory for gastric mucosal protection derived, in effect, from the very common industrial practice of adsorbing surfactants to surfaces needing protection against acid. Standard physical tests have been employed to show that sucralfate is highly surface-active at both liquid and solid interfaces, with the capability to be adsorbed--but not as active as the indigenous surface-active phospholipid (SAPL). This finding can explain the ability of sucralfate to "bind" to an ulcer site. Unlike SAPL or surfactants in general, adsorbed sucralfate does not render hydrophilic surfaces hydrophobic, suggesting a dual role in substituting for both SAPL and the mucus needed to stabilize it. Electron microscopy, using a novel fixation procedure specifically designed to allow for the known properties of any gastric mucosal barrier, revealed essentially the same oligolamellar lining of SAPL as previously reported in rats. Prolonged (16-day) exposure to sucralfate did not appear to change the situation, whereas there were as many, if not more, lamellar bodies (freshly secreted SAPL) adjacent to the stomach wall. Mucus-free oxyntic ducts showed the same oligolamellar lining as controls. An interesting new finding was the presence of oligolamellar SAPL as the intergranular matrix of gastric mucus--as though preparing to protect the next layer in anticipation of the surface mucin granules being eroded.
Similar articles
-
A mucosal barrier of gastric surfactant identified in the human stomach.Aust N Z J Med. 1992 Aug;22(4):441-4. doi: 10.1111/j.1445-5994.1992.tb02167.x. Aust N Z J Med. 1992. PMID: 1445032
-
Gastric mucosal barrier: intergranular matrix of gastric surfactant in the mucous lining.J Gastroenterol Hepatol. 1992 May-Jun;7(3):305-7. doi: 10.1111/j.1440-1746.1992.tb00986.x. J Gastroenterol Hepatol. 1992. PMID: 1611019
-
Enhancement of the protective qualities of gastric mucus by sucralfate: role of phosphoinositides.Am J Med. 1991 Aug 8;91(2A):30S-36S. doi: 10.1016/0002-9343(91)90448-7. Am J Med. 1991. PMID: 1715671
-
Surface-active phospholipid: a Pandora's box of clinical applications. Part II. Barrier and lubricating properties.Intern Med J. 2002 May-Jun;32(5-6):242-51. doi: 10.1046/j.1445-5994.2002.00201.x. Intern Med J. 2002. PMID: 12036223 Review.
-
Mechanisms of gastroduodenal protection by sucralfate.Am J Med. 1991 Aug 8;91(2A):58S-63S. doi: 10.1016/0002-9343(91)90452-4. Am J Med. 1991. PMID: 1715673 Review.
Cited by
-
Differences in surfactant lipids collected from pleural and pulmonary lining fluids.Pharm Res. 2005 Nov;22(11):1926-30. doi: 10.1007/s11095-005-7677-y. Epub 2005 Aug 19. Pharm Res. 2005. PMID: 16132340
-
Effect of sucralfate on components of mucosal barrier produced by cultured canine epithelial cells in vitro.Dig Dis Sci. 1992 Dec;37(12):1853-9. doi: 10.1007/BF01308079. Dig Dis Sci. 1992. PMID: 1473434
-
Unsaturated phosphatidylcholines lining on the surface of cartilage and its possible physiological roles.J Orthop Surg Res. 2007 Aug 23;2:14. doi: 10.1186/1749-799X-2-14. J Orthop Surg Res. 2007. PMID: 17718898 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous